Download this whitepaper and read through Camfil's 10 tips on the most important factors to consider when determining reliable dust collection solutions for tablet press applications.
Datwyler Healthcare's Tabassam Sharif, regulatory affairs manager and Eugene Polini, technical key account manager, explain how parenteral packaging suppliers are optimising their technologies and processes to meet regulatory requirements.
Rebekah Jordan shares her view from the seat at the Editor’s Desk on what impact the post-Brexit era might have on the UK process of medicine approvals and how external pharma manufacturers may respond.
Kry is expanding its chronic disease management and population health solutions with the launch of new treatment pathways for obesity. Through boosting access, Kry hopes to keep patients healthier for longer, reducing the need for medical treatments.
A digestive supplement known as, JUVIA Digestive Balance Formula, has recently been launched to treat people with IBS, powered by plants and backed up by science.
EPM spoke exclusively with Heiko Schmidt, Strategy & Consulting Life Sciences lead, Accenture AG, about why CDMOs should be prepared to track sustainability metrics now and how companies which wait, will likely be forced to catch-up at higher costs.
Rebekah Jordan fired out some quick Q&As with the Verseon team to shed light on their PKI treatment for diabetic vision loss, its advantages over injection treatments as well as its effectiveness long term.
Rebekah Jordan sits with Marty Gauvin, CEO of Fertilis, to discuss its IVF treatment innovation that replicates nature and automates the cell culture process, as well as its potential applications in regenerative medicine.
Following the success of its laboratory for process development in India, ACG, is now also committed to launching a sister process lab in Mulheium, Germany in 2023.
Portescap’s Jigar Fulia and Kanti Vala consider the selection criteria for biologics system motion solutions in delivery devices, and how this can help meet patient needs.
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process.
Ben Appleton and Mohammed Khimji from patent and trade mark firm, Wilson Gunn, explore the complexities, as well as the possibilities, of obtaining patent protection in Europe for inventions relating to biomarkers.
